Pig Makes Lymphoma History

A 730-pound pig has made history as the first of its species to successfully undergo treatment for lymphoma.

One of farmer and animal lover George Goldner's six massive pigs had not only stopped eating, but this one, named Nemo, was just laying in the mud.

Concerned, Goldner took Nemo by trailer to Cornell University Hospital for Animals (CUHA) in Ithaca, N.Y., where the 4-year-old Hampshire pig was diagnosed with B-cell lymphoma.

Unfortunately, no one knew what to do next.

Searching for a treatment

Undaunted, Goldner told the doctors to figure out what to do for Nemo and not to be concerned with how much it cost.

That was almost five months ago, and today Nemo is believed to be in remission and part of the history books as the first known pig with B-cell lymphoma to be successfully treated.

A step forward

In the wake of this success, researchers believe there might be hope for other large animals in similar circumstances.

Emily Barrell, a CUHA resident whose job it was to both determine what chemotherapy drugs to use and how to deliver it said:

Before when large animals were diagnosed with cancer, it was pretty much impossible to treat them. Now we have a model to base it on.

One of the problems the doctors had to overcome was the fact that pigs do not have easily accessible veins like humans, so researchers at CUHA had to implant a vascular access port under the pig's skin behind his ear to deliver the chemotherapy.

Goldner's dedication to his animal is being hailed by the likes of PETA and others.

"There were two choices," Goldner said. "One was to let him die and the other was to give it a shot."

Source: Various outlets

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap